iBio, Inc. Gains 30%
Mon, Aug 24, 2020 at 05:30 PM
iBio, Inc. (IBIO:NYSEMKT) soared at $2.21, representing a gain of 30%. On Fri 21 Aug 20, IBIO:NYSEMKT touched a New 2-Week Low of $1.7. The stock appeared on our News Catalysts scanner on Mon 10 Aug 20 at 07:28 AM in the 'BIOTECH' category. From Fri 07 Aug 20, the stock recorded 20.00% Up Days and 9.09% Green Days
The stock spiked on Tue 21 Jul 20 at $7.45 with a volume of 107M+.
About iBio, Inc. (IBIO:NYSEMKT)
iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.
Top 10 Gainers:
- Cancer Genetics, Inc. (CGIX:NASDAQ), 114.78%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 48.29%
- Borqs Technologies, Inc. (BRQS:NASDAQ), 39.46%
- Tortoise Acquisition Corp. (SHLL:NYSE), 33.73%
- iBio, Inc. (IBIO:NYSEMKT), 30%
- TravelCenters of America Inc. (TA:NASDAQ), 29.61%
- VivoPower International PLC (VVPR:NASDAQ), 25.57%
- CNS Pharmaceuticals, Inc. (CNSP:NASDAQ), 24.86%
- Gulfport Energy Corporation (GPOR:NASDAQ), 24.18%
- AutoWeb, Inc. (AUTO:NASDAQ), 24.1%